2B Scientific Announce New Tool for Apoptosis, Flow Cytometry and Microscopy
2B Scientific, a leading UK distributor of life science reagents announce a new tool for scientists working in the field of apoptosis, pSIVA - Polarity Sensitive Indicator of Viability and Apoptosis from IMGENEX Corporation.
- (1888PressRelease) January 18, 2012 - Oxford, UK - This new tool for apoptosis, flow cytometry and microscopy is the first reversible probe for detecting phosphatidlyserine (PS) on plasma membranes. The reversible nature of the probe differentiates it from previous products which are all characterized by irreversible binding. This new capability opens up types of analysis previously unavailable to scientists.
pSIVA is an annexin based, polarity sensitive probe for the spatiotemporal or kinetic analysis of apoptosis and other forms of cell death. The new probes reversible binding enables researchers, for the first time, to detect transient PS exposure which is associated with both normal physiological processes as well as reversible or rescuable apoptosis cell death events.
Passing comment, James Bernard CEO of 2B Scientific said, "We are delighted to announce the availability of another novel and innovative product from IMGENEX that will provide our customers with an analytical advantage over traditional apoptosis probes, pSIVA novel binding capabilities will allow scientists to analyse and quantify new aspects of apoptosis previously unattainable to researchers."
About the company, 2B Scientific is a specialist distributor of immunological reagents to the UK life science market. 2B Scientific take a novel approach to life science reagents distribution and provide a wide range of products including antibodies, PCR and flow cytometry reagents, proteins, kits and life science consumables.
Contact:
Mathew Taylor
Director
Algorythm Solutions Ltd
10 Torkington St
Stamford
Lincolnshire PE9 2UY
+44 (0)773 403 2112
mtaylor ( @ ) algorythmsolutions dot com
http://www.algorythmsolutions.com
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam